Sangui Biotech International, Inc.
OTC: SGBI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Thomas Striepe
- Headquarters
- Hamburg, Germany
- IPO year
- 1997
- Market cap
- $42.0K
- Website
- https://www.sanguibiotech.com
Loading SGBI…
Loading profile data…Frequently asked questions about SGBI
What does Sangui Biotech International, Inc. (SGBI) do?
Sangui Biotech International, Inc., through its subsidiary Sangui BioTech GmbH, specializes in creating artificial oxygen carriers derived from hemoglobin. These innovative products are utilized as blood supplements, blood volume replacements, and various related formulations. The company's oxygen carriers are vital for delivering oxygen to huma...
Where does SGBI trade?
Sangui Biotech International, Inc. (SGBI) trades on the Other OTC.
What sector is SGBI in?
Sangui Biotech International, Inc. (SGBI) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Sangui Biotech International, Inc.?
Thomas Striepe is the chief executive officer of Sangui Biotech International, Inc. (SGBI).
Where is Sangui Biotech International, Inc. headquartered?
Sangui Biotech International, Inc. is headquartered in Germany.
Does SGBI pay a dividend?
Sangui Biotech International, Inc. (SGBI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SGBI go public?
Sangui Biotech International, Inc. (SGBI) completed its initial public offering in 1997.